Content of review 1, reviewed on August 19, 2013
THE STUDY
Were any of the patients with discrepant staining patterns excluded? The authors have adequately described the status of the patients used in the study but do not comment on exclusion criteria, if any
RESULTS & CONCLUSIONS
Do the various drug treatments alter the ANA patterns? Since a significant number of patients were on some sort of disease modifying drug, the table should indicate the category of drug and the predominant ANA pattern.
Where mixed ANA patterns are observed, sera should be further dluted and IF assys performed to assess the most dominant pattern
Please include representative IF images of other ANA (oANA) pattern. Were these patients on any "disease modifying drug"?
It would be helpful to have RF and Blys/BAFF titers of these patients.
Source
© 2013 the Reviewer (source).
References
Martina, F., Orjan, D., Alf, K., Thomas, S., Christopher, S. 2013. Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open, 3(10).